Zymogen inhibition

pathway activity — cross-omics
GO:0097341Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Zymogen inhibition pathway is significantly associated with the protein abundance of multiple proteins, with the OV cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are DOCK2, FYB1, and GBP2, each associated with the pathway in up to 10 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile.

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVDOCK2 →+0.572+0.071<.001<.001310
GBMFYB1 →+0.518+0.087<.001<.001310
GBMGBP2 →+0.715+0.110<.001<.001310
UCECGIMAP7 →+0.623+0.156<.001<.001310
OVARHGAP45 →+0.495+0.059<.001<.001310
GBMMYO1F →+0.492+0.087<.001<.001310
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

Exploration